NCT04814771

Mass Balance Study of TS-142 in Healthy Adult Subjects.

Mass Balance Recovery, Pharmacokinetics, Metabolite Identification and Profiling of 14C-labeled TS-142 in Healthy Adult Subjects.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Taisho Pharmaceutical Co., Ltd. · Industry
• Sex: Male
• Age: 20 Years – 39 Years
• Healthy volunteers: Accepted

Summary

To assess the plasma pharmacokinetics, the routes extent of elimination, and the metabolites of TS-142 after single oral dose of \[14C\] TS-142 in Japanese healthy male subjects. To assess the safety of single oral dose of \[14C\] TS-142 in Japanese healthy male subjects.

Conditions

• Healthy Male Subjects

Interventions

Type	Name	Description
DRUG	[14C] TS-142	Subjects received single dose of 7.5 mg of TS-142 containing 20 kBq \[14C\]TS-142 as an oral solution

Timeline

• Start date: 2021-04-19
• Primary completion: 2021-05-19
• Completion: 2021-05-19
• First posted: 2021-03-24
• Last updated: 2025-02-28

Locations

1 site across 1 country: Japan